Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judit Börcsök

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Plos Computational Biology|September 17, 2021
Hierarchy and control of ageing-related methylation networksGergely Palla, Péter Pollner, Judit Börcsök, et al.
Scientific Reports|January 15, 2024
Biologically informed deep learning for explainable epigenetic clocksAurel Prosz, Orsolya Pipek, Judit Börcsök, et al.
NPJ Precision Oncology|June 20, 2025
Polymerase theta expression is correlated with proliferative capacity but not with DNA repair deficiency status in solid tumorsZsofia Sztupinszki, Regina Fiam, Orsolya Pipek, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Identification of an <i>ERCC2</i> mutation associated mutational signature of nucleotide excision repair deficiency in targeted panel sequencing dataOlivera Stojkova, Judit Börcsök, Zsofia Sztupinszki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2021
Detection of Molecular Signatures of Homologous Recombination Deficiency in Bladder CancerJudit Börcsök, Miklos Diossy, Zsofia Sztupinszki, et al.
Cancer Research|July 3, 2021
Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human CancersJintao Guo, Ying Zhou, Chaoqun Xu, et al.
The Journal of Clinical Investigation|August 19, 2025
Quantitative functional profiling of ERCC2 mutations deciphers cisplatin sensitivity in bladder cancerJudit Börcsök, Diyavarshini Gopaul, Daphne Devesa-Serrano, et al.
Scientific Reports|November 23, 2023
Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinomaAurel Prosz, Haohui Duan, Viktoria Tisza, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinomaAurel Prosz, Haohui Duan, Viktoria Tisza, et al.
JCI Insight|April 22, 2025
G6PC3 promotes genome maintenance and is a candidate mammary tumor suppressorXin Li, Maria Rossing, Ana Moisés da Silva, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Plos Computational Biology|September 17, 2021
Hierarchy and control of ageing-related methylation networksGergely Palla, Péter Pollner, Judit Börcsök, et al.
Scientific Reports|January 15, 2024
Biologically informed deep learning for explainable epigenetic clocksAurel Prosz, Orsolya Pipek, Judit Börcsök, et al.
NPJ Precision Oncology|June 20, 2025
Polymerase theta expression is correlated with proliferative capacity but not with DNA repair deficiency status in solid tumorsZsofia Sztupinszki, Regina Fiam, Orsolya Pipek, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Identification of an <i>ERCC2</i> mutation associated mutational signature of nucleotide excision repair deficiency in targeted panel sequencing dataOlivera Stojkova, Judit Börcsök, Zsofia Sztupinszki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2021
Detection of Molecular Signatures of Homologous Recombination Deficiency in Bladder CancerJudit Börcsök, Miklos Diossy, Zsofia Sztupinszki, et al.
Cancer Research|July 3, 2021
Genetic Determinants of Somatic Selection of Mutational Processes in 3,566 Human CancersJintao Guo, Ying Zhou, Chaoqun Xu, et al.
The Journal of Clinical Investigation|August 19, 2025
Quantitative functional profiling of ERCC2 mutations deciphers cisplatin sensitivity in bladder cancerJudit Börcsök, Diyavarshini Gopaul, Daphne Devesa-Serrano, et al.
Scientific Reports|November 23, 2023
Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinomaAurel Prosz, Haohui Duan, Viktoria Tisza, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2023
Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinomaAurel Prosz, Haohui Duan, Viktoria Tisza, et al.
JCI Insight|April 22, 2025
G6PC3 promotes genome maintenance and is a candidate mammary tumor suppressorXin Li, Maria Rossing, Ana Moisés da Silva, et al.
Pageof 2